Kynam Capital Management LP 13D/13G Filings for Sutro Biopharma, Inc. (STRO)

Kynam Capital Management LP 13D and 13G filings for Sutro Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-15
11:39 am
Purchase		 2025-03-31 13G Sutro Biopharma, Inc.
STRO		 Kynam Capital Management LP 5,441,447
6.440%		 5,441,447increase
(New Position)		 Filing